Cite

    Harris, P. et al. (n.d.). Β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?. Lancet infectious diseases. 15 (4), pp. 475-485. [Online].